LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 399

Search options

  1. Article ; Online: The eQTL analysis to discover unique eGFR-related SNPs for the Taiwanese population.

    Wu, Ping-Hsun / Lin, Johnathan / Kuo, Mei-Chuan / Yu, Sung-Huan

    Journal of nephrology

    2023  Volume 37, Issue 1, Page(s) 249–252

    MeSH term(s) Humans ; Polymorphism, Single Nucleotide ; Genetic Predisposition to Disease ; Genome-Wide Association Study
    Language English
    Publishing date 2023-10-19
    Publishing country Italy
    Document type Letter
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-023-01793-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Therapeutic plasma exchange for refractory vaccine-induced immune thrombotic thrombocytopenia.

    Fan, Sheng-Bin / Tsai, Ming-Ju / Kuo, Mei-Chuan / Chuang, Cheng-Hao

    The Kaohsiung journal of medical sciences

    2022  Volume 38, Issue 8, Page(s) 804–805

    MeSH term(s) Humans ; Plasma Exchange ; Thrombocytopenia/therapy ; Thrombosis ; Vaccines
    Chemical Substances Vaccines
    Language English
    Publishing date 2022-04-12
    Publishing country China (Republic : 1949- )
    Document type Letter
    ZDB-ID 639302-0
    ISSN 2410-8650 ; 0257-5655
    ISSN (online) 2410-8650
    ISSN 0257-5655
    DOI 10.1002/kjm2.12549
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma.

    Weng, Chih-Ming / Wu, Wei-Ciao / Lee, Meng-Jung / Chen, Mei-Chuan / Chou, Chun-Liang / Lin, Chun-Yu / Chung, Kian Fan / Kuo, Han-Pin

    Respirology (Carlton, Vic.)

    2024  Volume 29, Issue 3, Page(s) 252–255

    MeSH term(s) Humans ; Omalizumab/therapeutic use ; Enterotoxins/therapeutic use ; Asthma/drug therapy ; Anti-Asthmatic Agents/therapeutic use ; Immunoglobulin E
    Chemical Substances Omalizumab (2P471X1Z11) ; Enterotoxins ; Anti-Asthmatic Agents ; Immunoglobulin E (37341-29-0)
    Language English
    Publishing date 2024-01-31
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 1435849-9
    ISSN 1440-1843 ; 1323-7799
    ISSN (online) 1440-1843
    ISSN 1323-7799
    DOI 10.1111/resp.14663
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Therapeutic plasma exchange for refractory vaccine‐induced immune thrombotic thrombocytopenia

    Sheng‐Bin Fan / Ming‐Ju Tsai / Mei‐Chuan Kuo / Cheng‐Hao Chuang

    Kaohsiung Journal of Medical Sciences, Vol 38, Iss 8, Pp 804-

    2022  Volume 805

    Keywords Medicine (General) ; R5-920
    Language English
    Publishing date 2022-08-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Podocentric view of glomerular proteinuria: Focused on cytoskeletal changes and toward promising targeted therapies and challenges.

    Kuo, Mei-Chuan / Liang, Peir-In / Chang, Jer-Ming

    The Kaohsiung journal of medical sciences

    2021  Volume 37, Issue 7, Page(s) 539–546

    Abstract: Among renal cells, podocytes (glomerular epithelial cells) are the most critical to prevent plasma proteins from excessive loss by forming their sophisticated foot processes (FP) and slit diaphragms (SD). A general finding in the glomeruli of patients ... ...

    Abstract Among renal cells, podocytes (glomerular epithelial cells) are the most critical to prevent plasma proteins from excessive loss by forming their sophisticated foot processes (FP) and slit diaphragms (SD). A general finding in the glomeruli of patients with nephrotic syndrome is the foot processes "effacement" resulted from dysregulated actin cytoskeleton reorganization. Ultrastructural analysis in patients with nephrotic syndrome has demonstrated that such changes tend to be dynamic and can sometimes be reversible. In a more molecular sense, injured podocytes can no longer maintain their tight regulation and "retract" their FP, but not "efface" them. Past studies have revealed multiple exquisite mechanisms and arrays of proteins participating in the regulation of cytoskeletal rearrangement, and these mechanisms serve as potential targets to treat. A major challenge to develop specific therapies is the targeted mechanism has to be crucial and specific enough for podocyte-oriented kidney diseases, and it would be even better to manifest in most of the glomerulonephritis. Studies have shown many approaches targeting different mechanisms, but none of them has been proved to be effective in clinical medicine. Up to the present, Abatacept (Orencia) is the first (and the only) clinical targeted therapy demonstrating limited success. It inhibits the co-stimulatory response of B7-1 (CD80) induced in various types of glomerulonephritis. Future clinical studies have to be expanded to substantiate this highly specific targeted therapy because the Abatacept effect is not generally accepted even within the nephrology community. Nevertheless, there are ongoing searches for specific treatment targeting podocytes through various approaches.
    MeSH term(s) Abatacept/pharmacology ; Animals ; B7-1 Antigen/metabolism ; Basement Membrane/metabolism ; Cytoskeleton/metabolism ; Epithelial Cells ; Glomerulonephritis/metabolism ; Glomerulonephritis/therapy ; Humans ; Kidney/metabolism ; Kidney Glomerulus/metabolism ; Mice ; Nephrology/methods ; Nephrotic Syndrome/metabolism ; Nephrotic Syndrome/therapy ; Podocytes/metabolism ; Proteinuria ; Rats ; Signal Transduction
    Chemical Substances B7-1 Antigen ; CD80 protein, human ; Abatacept (7D0YB67S97)
    Language English
    Publishing date 2021-05-04
    Publishing country China (Republic : 1949- )
    Document type Journal Article ; Review
    ZDB-ID 639302-0
    ISSN 2410-8650 ; 0257-5655
    ISSN (online) 2410-8650
    ISSN 0257-5655
    DOI 10.1002/kjm2.12385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19.

    Wu, Jheng-Yan / Liu, Mei-Yuan / Lee, Mei-Chuan / Hung, Kuo-Chuan / Hsu, Wan-Hsuan / Tsai, Ya-Wen / Liu, Ting-Hui / Huang, Po-Yu / Chuang, Min-Hsiang / Tseng, Shu-Ching / Lu, Chih-Ying / Lai, Chih-Cheng

    Expert review of anti-infective therapy

    2024  , Page(s) 1–10

    Abstract: Objectives: This study investigated the outcomes of underweight patients with COVID-19 and the effectiveness of antiviral agents in this population.: Methods: A retrospective cohort study using theTriNetX research network was conducted. Propensity ... ...

    Abstract Objectives: This study investigated the outcomes of underweight patients with COVID-19 and the effectiveness of antiviral agents in this population.
    Methods: A retrospective cohort study using theTriNetX research network was conducted. Propensity score matching (PSM) was employed to balance the first cohort involving COVID-19 patients with underweight and normal-weight. In the second cohort, underweight patients receiving antiviral agents and untreated individuals were matched using PSM. The primary outcome was a composite of all-cause hospitalization and death during the 7-30-day follow-up period.
    Results: After PSM, the first cohort including each group of 13,502 patients with balanced baseline characteristics were identified for comparing the outcome of patients with underweight and normal weight. The underweight group had a higher risk of the composite primary outcome than those with normal weight (hazard ratio [HR], 1.251; 95% confidence interval [CI], 1.132-1.382). The second cohort included each 884 underweight patients with and without receiving antivirals.Compared with untreated patients, those receiving antiviral treatment had a lower risk of composite primary outcomes (HR, 0.426; 95% CI, 0.278-0.653).
    Conclusion: Underweight status may be associated with a higher risk of all-cause hospitalization and death in patients with COVID-19.Among underweight patients, antiviral agents demonstrated clinically beneficial effects.
    Language English
    Publishing date 2024-01-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2181279-2
    ISSN 1744-8336 ; 1478-7210
    ISSN (online) 1744-8336
    ISSN 1478-7210
    DOI 10.1080/14787210.2024.2303017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Podocentric view of glomerular proteinuria

    Mei‐Chuan Kuo / Peir‐In Liang / Jer‐Ming Chang

    Kaohsiung Journal of Medical Sciences, Vol 37, Iss 7, Pp 539-

    Focused on cytoskeletal changes and toward promising targeted therapies and challenges

    2021  Volume 546

    Abstract: Abstract Among renal cells, podocytes (glomerular epithelial cells) are the most critical to prevent plasma proteins from excessive loss by forming their sophisticated foot processes (FP) and slit diaphragms (SD). A general finding in the glomeruli of ... ...

    Abstract Abstract Among renal cells, podocytes (glomerular epithelial cells) are the most critical to prevent plasma proteins from excessive loss by forming their sophisticated foot processes (FP) and slit diaphragms (SD). A general finding in the glomeruli of patients with nephrotic syndrome is the foot processes “effacement” resulted from dysregulated actin cytoskeleton reorganization. Ultrastructural analysis in patients with nephrotic syndrome has demonstrated that such changes tend to be dynamic and can sometimes be reversible. In a more molecular sense, injured podocytes can no longer maintain their tight regulation and “retract” their FP, but not “efface” them. Past studies have revealed multiple exquisite mechanisms and arrays of proteins participating in the regulation of cytoskeletal rearrangement, and these mechanisms serve as potential targets to treat. A major challenge to develop specific therapies is the targeted mechanism has to be crucial and specific enough for podocyte‐oriented kidney diseases, and it would be even better to manifest in most of the glomerulonephritis. Studies have shown many approaches targeting different mechanisms, but none of them has been proved to be effective in clinical medicine. Up to the present, Abatacept (Orencia) is the first (and the only) clinical targeted therapy demonstrating limited success. It inhibits the co‐stimulatory response of B7‐1 (CD80) induced in various types of glomerulonephritis. Future clinical studies have to be expanded to substantiate this highly specific targeted therapy because the Abatacept effect is not generally accepted even within the nephrology community. Nevertheless, there are ongoing searches for specific treatment targeting podocytes through various approaches.
    Keywords actin cytoskeleton ; foot processes ; podocytes ; proteinuria ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2021-07-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Exploring the Relationship between Gut Microbiome Composition and Blood Indole-3-acetic Acid in Hemodialysis Patients.

    Wu, Ping-Hsun / Tseng, Yu-Fang / Liu, Wangta / Chuang, Yun-Shiuan / Tai, Chi-Jung / Tung, Chun-Wei / Lai, Kean-Yee / Kuo, Mei-Chuan / Chiu, Yi-Wen / Hwang, Shang-Jyh / Hung, Wei-Chun / Lin, Yi-Ting

    Biomedicines

    2024  Volume 12, Issue 1

    Abstract: Indole-3-acetic acid (IAA), a protein-bound uremic toxin resulting from gut microbiota-driven tryptophan metabolism, increases in hemodialysis (HD) patients. IAA may induce endothelial dysfunction, inflammation, and oxidative stress, elevating ... ...

    Abstract Indole-3-acetic acid (IAA), a protein-bound uremic toxin resulting from gut microbiota-driven tryptophan metabolism, increases in hemodialysis (HD) patients. IAA may induce endothelial dysfunction, inflammation, and oxidative stress, elevating cardiovascular and cognitive risk in HD patients. However, research on the microbiome-IAA association is limited. This study aimed to explore the gut microbiome's relationship with plasma IAA levels in 72 chronic HD patients aged over 18 (August 2016-January 2017). IAA levels were measured using tandem mass spectrometry, and gut microbiome analysis utilized 16s rRNA next-generation sequencing. Linear discriminative analysis effect size and random forest analysis distinguished microbial species linked to IAA levels. Patients with higher IAA levels had reduced microbial diversity. Six microbial species significantly associated with IAA levels were identified;
    Language English
    Publishing date 2024-01-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines12010148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease.

    Chen, Chia-Chen / Huang, Chi-Ya / Wu, Jheng-Yan / Liu, Mei-Yuan / Chuang, Min-Hsiang / Liu, Ting-Hui / Tsai, Ya-Wen / Hsu, Wan-Hsuan / Huang, Po-Yu / Chen, Ming-Hui / Liu, Su-Yen / Lee, Mei-Chuan / Hung, Kuo-Chuan / Lai, Chih-Cheng / Yang, I-Ning

    Expert review of anti-infective therapy

    2024  , Page(s) 1–8

    Abstract: Objectives: This study examined the effectiveness of nirmatrelvir plus ritonavir (NMV-r) and molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients.: Methods: This retrospective cohort study, using the TriNetX research ... ...

    Abstract Objectives: This study examined the effectiveness of nirmatrelvir plus ritonavir (NMV-r) and molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients.
    Methods: This retrospective cohort study, using the TriNetX research network, identified stage 3-5 CKD and end-stage kidney disease (ESKD) patients with non-hospitalized COVID-19 between 1 January 2022, and 31 May 2023. Propensity score matching (PSM) was used to compare patients on NMV-r or MOV (antiviral group) against those not receiving these treatments (control group). The primary composite outcome was the cumulative hazard ratio (HR) for all-cause hospitalization or death within the 30-day follow-up.
    Results: After PSM, two balanced cohorts of 6,275 patients each were established. The antiviral group exhibited a lower incidence of all-cause hospitalization or mortality (5.93% vs. 9.53%; HR: 0.626; 95% CI: 0.550-0.713) than controls. Additionally, antiviral recipients were associated with a lower risk of all-cause hospitalization (HR: 0.679; 95% CI: 0.594-0.777) and mortality (HR: 0.338; 95% CI: 0.227-0.504). The beneficial effects of antiviral agents were consistent across sex, age, vaccination status, antiviral type, and CKD stage.
    Conclusion: Oral antiviral agents could be associated with lower rates of all-cause hospitalization or death among non-hospitalized COVID-19 patients with CKD.
    Language English
    Publishing date 2024-03-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2181279-2
    ISSN 1744-8336 ; 1478-7210
    ISSN (online) 1744-8336
    ISSN 1478-7210
    DOI 10.1080/14787210.2024.2334052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.

    Tsai, Yi-Chun / Kuo, Mei-Chuan / Hung, Wei-Wen / Wu, Ping-Hsun / Chang, Wei-An / Wu, Ling-Yu / Lee, Su-Chu / Hsu, Ya-Ling

    Cell communication and signaling : CCS

    2023  Volume 21, Issue 1, Page(s) 10

    Abstract: Background: Diabetic nephropathy (DN) is an increasing threat to human health and regarded to be the leading cause of end-stage renal disease worldwide. Exosomes delivery may play a key role in cross-talk among kidney cells and the progression of DN. ... ...

    Abstract Background: Diabetic nephropathy (DN) is an increasing threat to human health and regarded to be the leading cause of end-stage renal disease worldwide. Exosomes delivery may play a key role in cross-talk among kidney cells and the progression of DN. However, the mechanisms underlying exosomes in DN remain unclear.
    Methods: The cross-disciplinary study, including in vivo, in vitro, and human studies was conducted to explore the cross-talk between proximal tubular epithelial cells (PTECs) and mesangial cells (MCs) in DN. We purified exosome from PTECs treated with high glucose and db/db mice and assessed their influences in the pathologic change of MCs and downstream signal pathway. Healthy individuals and type 2 diabetic patients were enrolled to examine the role of exosomes in clinical applications.
    Results: High glucose stimulated PTECs to secrete exosomal miR-92a-1-5p, which was taken-up by glomerular MCs, inducing myofibroblast transdifferentiation (MFT) in vitro and in vivo. PTEC-released exosomal 92a-1-5p decreased reticulocalbin-3 expression, leading to endoplasmic reticulum (ER) stress by downregulating genes essential for ER homeostasis including calreticulin and mesencephalic astrocyte-derived neurotrophic factor. Treatment with miR-92a-1-5p inhibitor ameliorated kidney damage in db/db mice with DN. Urinary miR-92a-1-5p could predict kidney injury in type 2 diabetic patients.
    Conclusions: PTEC-derived exosomal miR-92a-1-5p modulated the kidney microenvironment in vivo and in vitro models, which altered ER stress and MFT in MCs resulting in DN progression. Further blocking miR-92a-1-5p epigenetic regulatory network could be a potential therapeutic strategy to prevent the progression of DN. Video Abstract.
    MeSH term(s) Animals ; Humans ; Mice ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Diabetic Nephropathies/metabolism ; Exosomes/metabolism ; Glucose/metabolism ; Mesangial Cells/metabolism ; MicroRNAs/genetics ; MicroRNAs/metabolism
    Chemical Substances Glucose (IY9XDZ35W2) ; MicroRNAs ; MIRN92 microRNA, human
    Language English
    Publishing date 2023-01-13
    Publishing country England
    Document type Video-Audio Media ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2126315-2
    ISSN 1478-811X ; 1478-811X
    ISSN (online) 1478-811X
    ISSN 1478-811X
    DOI 10.1186/s12964-022-00997-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top